JNJ-26070109...

JNJ-26070109 [(R)4-Bromo-N-[1-(2,4-difluoro-phenyl)-ethyl]-2-(quinoxaline-5-sulfonylamino)-benzamide]: A Novel, Potent, and Selective Cholecystokinin 2 Receptor Antagonist with Good Oral Bioavailability

Morton, M. F., Barrett, T. D., Freedman, J., Li, L., Rizzolio, M. C., Prendergast, C. E., Wu, X., Moreno, V., Pyati, J., Figueroa, K., Cagnon, L., Lagaud, G., Ver Donck, L., Ghoos, E., Allison, B., Ra
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
338
Language:
english
Journal:
Journal of Pharmacology and Experimental Therapeutics
DOI:
10.1124/jpet.110.178483
Date:
July, 2011
File:
PDF, 1.71 MB
english, 2011
Conversion to is in progress
Conversion to is failed